| The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures (NCT05664633) | West Virginia University | 2023-08-01 |
| Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. (NCT05753826) | Fujian Cancer Hospital | 2023-08-01 |
| Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) (NCT05184101) | Australian National University | 2023-08-01 |
| Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections (NCT06050148) | Helsinki University Central Hospital | 2023-08-01 |
| Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies (NCT05920889) | Chinese University of Hong Kong | 2023-08-01 |
| HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma (NCT05821361) | Tianjin Medical University Cancer Institute and Hospital | 2023-08-01 |
| Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) (NCT05877508) | Michael Peluso, MD | 2023-08-01 |
| Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients (NCT06544109) | The First Affiliated Hospital of Soochow University | 2023-08-01 |
| Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT05955209) | Peking University Cancer Hospital & Institute | 2023-08-01 |
| Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease (NCT05575037) | Brigham and Women's Hospital | 2023-08-01 |
| Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease Patients (NCT05710367) | Albina Nowak, MD | 2023-08-01 |
| 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses (NCT05879510) | Peking Union Medical College Hospital | 2023-08-01 |
| PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma (NCT05714306) | Centre Hospitalier Universitaire Vaudois | 2023-08-01 |
| A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat (NCT05320380) | Children's Oncology Group | 2023-08-01 |
| RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC (NCT05979740) | RenJi Hospital | 2023-08-01 |
| Immunotherapy for Advanced Liver Cancer (NCT05033522) | Mirror Biologics, Inc. | 2023-08-01 |
| Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) (NCT05896787) | The First Affiliated Hospital of Zhengzhou University | 2023-08-01 |
| A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors (NCT05985161) | Memorial Sloan Kettering Cancer Center | 2023-08-01 |
| A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia (NCT05979948) | Shanghai Changzheng Hospital | 2023-08-01 |
| Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults (NCT05972733) | HilleVax | 2023-08-01 |
| Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination (NCT05859490) | Oregon Health and Science University | 2023-08-01 |
| Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors (NCT05887726) | Liaoning Cancer Hospital & Institute | 2023-08-01 |
| A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (NCT05998941) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-08-01 |
| Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer (NCT05965141) | Second Affiliated Hospital of Guangzhou Medical University | 2023-08-01 |
| Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures (NCT05738382) | Bio Genuine (Shanghai) Biotech Co., Ltd. | 2023-08-01 |
| Polyethylene-glycol Assisted Nerve Repair in Phalloplasty (NCT05897086) | Vanderbilt University Medical Center | 2023-08-01 |
| Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study (NCT05897372) | Iain Bressendorff | 2023-08-01 |
| Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer (NCT06123455) | Tang-Du Hospital | 2023-08-01 |
| Low Dose Versus High Dose Methylene Blue in Septic Patients (NCT06005558) | National Cancer Institute, Egypt | 2023-08-01 |
| Crisaborole Ointment for Skin Toxicity Induced by Cetuximab (NCT06118047) | Sun Yat-sen University | 2023-08-01 |
| Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities (NCT05623111) | Rigshospitalet, Denmark | 2023-08-01 |
| A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver (NCT05677113) | Sunnybrook Health Sciences Centre | 2023-08-01 |
| The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II): (NCT05986227) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-08-01 |
| Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer (NCT05554276) | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 2023-08-01 |
| Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients (NCT05901987) | GeneCradle Inc | 2023-08-01 |
| The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery. (NCT05949229) | Amira Hassan Ahmed Ali | 2023-08-01 |
| Safety and Tolerability of Pirfenidone in Acute Pancreatitis (NCT05350371) | University of Alabama at Birmingham | 2023-08-01 |
| 68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion (NCT05879497) | Peking Union Medical College Hospital | 2023-08-01 |
| Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma (NCT05965154) | Second Affiliated Hospital of Guangzhou Medical University | 2023-08-01 |
| Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. (NCT06133088) | Zhejiang Cancer Hospital | 2023-08-01 |
| Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study (NCT05727384) | Anne B. Newman | 2023-08-01 |
| A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults (NCT05960097) | GlaxoSmithKline | 2023-08-01 |
| A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma (NCT05972720) | CARGO Therapeutics | 2023-08-01 |
| Perioperative Music Therapy Plus Oxycodone in Perioperative Management of Lung Surgery (NCT05981924) | Hao Long | 2023-08-01 |
| T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients (NCT05953168) | Fudan University | 2023-08-01 |
| The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC (NCT05904015) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-08-01 |
| Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer (NCT05914389) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-08-01 |
| A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC (NCT05773092) | National Cancer Centre, Singapore | 2023-08-01 |
| MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers (NCT05986981) | Peking Union Medical College Hospital | 2023-08-01 |
| A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors (NCT05678205) | Artiva Biotherapeutics, Inc. | 2023-08-01 |
| Effect of Use of Calcium Hydroxide and Metformin Intracanal Medicament After NSRCT (NCT06766201) | Postgraduate Institute of Dental Sciences Rohtak | 2023-08-01 |
| Oxytocin Effects on Bone in Children With Autism Spectrum Disorder (NCT05754073) | Elizabeth Austen Lawson | 2023-08-01 |
| Dexmedetomidine in Postoperative Analgesia (NCT05705128) | New Valley University | 2023-08-01 |
| Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis (NCT05455034) | Xinqiao Hospital of Chongqing | 2023-08-01 |
| INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients (NCT00455039) | University of New Mexico | 2023-07-31 |
| The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) (NCT05849246) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-07-31 |
| A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation. (NCT05967689) | Taiho Oncology, Inc. | 2023-07-31 |
| Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS) (NCT06017869) | Minovia Therapeutics Ltd. | 2023-07-31 |
| Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer (NCT06007092) | Gustave Roussy, Cancer Campus, Grand Paris | 2023-07-31 |
| Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM) (NCT05255666) | Washington University School of Medicine | 2023-07-31 |
| Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers (NCT05547464) | BioNTech SE | 2023-07-31 |
| Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy (NCT06201078) | Maria Sklodowska-Curie National Research Institute of Oncology | 2023-07-31 |
| A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer (NCT06007846) | Inova Health Care Services | 2023-07-31 |
| POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis (NCT05932654) | Biosion, Inc. | 2023-07-31 |
| A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder (NCT05941442) | AbbVie | 2023-07-31 |
| Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria (NCT05936567) | Incyte Corporation | 2023-07-31 |
| Topical Ruxolitinib Evaluation in Chronic Hand Eczema (NCT05906628) | Incyte Corporation | 2023-07-31 |
| A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC (NCT05394831) | J Ints Bio | 2023-07-30 |
| Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease (NCT05471492) | Telavant, Inc. | 2023-07-30 |
| The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC (NCT05862610) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-07-30 |
| Effect Of Azithromycin in Women at Risk of Preterm Labour (NCT05971654) | Beni-Suef University | 2023-07-30 |
| Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia (NCT05964790) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-07-30 |
| The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders (NCT05900661) | Beni-Suef University | 2023-07-30 |
| Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients (NCT05972928) | Beni-Suef University | 2023-07-30 |
| Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis (NCT05948982) | Asia Cell Therapeutics (Shanghai) Co., Ltd. | 2023-07-30 |
| Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes (NCT05971667) | Beni-Suef University | 2023-07-30 |
| A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors (NCT05789537) | ApcinteX Ltd | 2023-07-28 |
| Galunisertib Combined With Capecitabine in Advanced CRC With PM (NCT05700656) | The Netherlands Cancer Institute | 2023-07-28 |
| A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs) (NCT05905458) | Chengdu Suncadia Medicine Co., Ltd. | 2023-07-28 |
| Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) (NCT05935748) | NiKang Therapeutics, Inc. | 2023-07-28 |
| Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma (NCT05970627) | Yu jiren | 2023-07-28 |
| Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus (NCT05700513) | Tabriz University of Medical Sciences | 2023-07-28 |
| A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain (NCT05895552) | Reata, a wholly owned subsidiary of Biogen | 2023-07-28 |
| Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome (NCT05873712) | Aseel Alsouqi | 2023-07-28 |
| A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma (NCT05929612) | M.D. Anderson Cancer Center | 2023-07-28 |
| A Pan-TB Regimen Targeting Host and Microbe (NCT05686356) | The Aurum Institute NPC | 2023-07-28 |
| A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes (NCT05762107) | Zucara Therapeutics Inc. | 2023-07-28 |
| A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above (NCT05921903) | GlaxoSmithKline | 2023-07-28 |
| TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (NCT06114082) | Seoul National University Hospital | 2023-07-28 |
| Photobiomodulation in Chronic Knee Pain in Patients Who Are in PreRehabilitation for Bariatric Surgery (NCT05816798) | University of Nove de Julho | 2023-07-28 |
| Pembro With Radiation With or Without Olaparib (NCT05568550) | Zin W Myint | 2023-07-27 |
| XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. (NCT06792435) | Astellas Pharma Global Development, Inc. | 2023-07-27 |
| Lurbinectedin in FET-Fused Tumors (NCT05918640) | Children's Hospital of Philadelphia | 2023-07-27 |
| IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) (NCT05989711) | Altimmune, Inc. | 2023-07-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia (NCT05778188) | ReAlta Life Sciences, Inc. | 2023-07-27 |
| Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer (NCT06227117) | RemeGen Co., Ltd. | 2023-07-27 |
| A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. (NCT05630066) | Hoffmann-La Roche | 2023-07-27 |
| A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study (NCT05934331) | LaNova Medicines Zhejiang Co., Ltd. | 2023-07-27 |
| A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy (NCT05585281) | Yongpeng Wang | 2023-07-27 |
| Guanfacine Extended-release for Adolescents With Cannabis Use (NCT05957848) | Orygen | 2023-07-27 |